Showing 1 - 13 of 44
View by: Cover Page List Articles
-
Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II
published 26 Jun 2025
Loading metrics information...
Metrics unavailable. Please check back later.
-
Exploring the diagnostic potential of miRNA signatures in the Fabry disease serum: A comparative study of automated and manual sample isolations
published 28 Oct 2024
Loading metrics information...
Metrics unavailable. Please check back later.
-
Association between under-dose of enzyme replacement therapy and quality of life in adults with late-onset Pompe disease in China: A retrospective matched cohort study
published 17 Sep 2024
Loading metrics information...
Metrics unavailable. Please check back later.
-
Discovery of allosteric regulators with clinical potential to stabilize alpha-L-iduronidase in mucopolysaccharidosis type I
published 20 May 2024
Loading metrics information...
Metrics unavailable. Please check back later.
-
Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo
published 10 Nov 2022
Loading metrics information...
Metrics unavailable. Please check back later.
-
Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy
published 28 Sep 2020
Loading metrics information...
Metrics unavailable. Please check back later.
-
Self-association of human beta-galactocerebrosidase: Dependence on pH, salt, and surfactant
published 23 Dec 2019
Loading metrics information...
Metrics unavailable. Please check back later.
-
Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types
published 10 Oct 2019
Loading metrics information...
Metrics unavailable. Please check back later.
-
Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease
published 27 Jun 2019
Loading metrics information...
Metrics unavailable. Please check back later.
-
The ACE I/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease
published 07 Dec 2018
Loading metrics information...
Metrics unavailable. Please check back later.
-
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?
published 27 Sep 2018
Loading metrics information...
Metrics unavailable. Please check back later.
-
Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy
published 18 Sep 2018
Loading metrics information...
Metrics unavailable. Please check back later.
-
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation
published 05 Apr 2018
Loading metrics information...
Metrics unavailable. Please check back later.
Connect with Us